Pharmacy Plus, Inc., doing business as Vital Care Compounder, is recalling approximately 3,677 units of various compounded sterile drug products, including injectable solutions such as Semaglutide and Papaverine, as well as several types of ophthalmic (eye) drops. The recall was initiated following an FDA inspection which found that the products were manufactured in a way that does not guarantee they are sterile. Using non-sterile drugs that are meant to be sterile can lead to severe and potentially life-threatening infections. No injuries or specific incidents have been reported, but the manufacturer is voluntarily recalling the products as a precaution.
Products that lack sterility assurance can cause localized or systemic infections if they are contaminated with bacteria or fungi. These infections can be particularly dangerous when the drugs are injected or used in the eyes, potentially leading to hospitalization or permanent damage.
You have 2 options:
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.